<SEC-DOCUMENT>0000891293-15-000062-index.html : 20151204
<SEC-HEADER>0000891293-15-000062.hdr.sgml : 20151204
<ACCEPTANCE-DATETIME>20151204183030
ACCESSION NUMBER:		0000891293-15-000062
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20151204
FILED AS OF DATE:		20151204
DATE AS OF CHANGE:		20151204

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CTI BIOPHARMA CORP
		CENTRAL INDEX KEY:			0000891293
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				911533912
		STATE OF INCORPORATION:			WA
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		3101 WESTERN AVENUE
		STREET 2:		SUITE 600
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98121
		BUSINESS PHONE:		2062827100

	MAIL ADDRESS:	
		STREET 1:		3101 WESTERN AVENUE
		STREET 2:		SUITE 600
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CELL THERAPEUTICS INC
		DATE OF NAME CHANGE:	19960321

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Plunkett Matthew
		CENTRAL INDEX KEY:			0001557551

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12465
		FILM NUMBER:		151271014

	MAIL ADDRESS:	
		STREET 1:		3101 WESTERN AVENUE, SUITE 600
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98121
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>primary_doc.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>